- Description
- Specifications
Catalog #: IHA-014
Description:
Recombinant Hemagglutinin external envelope protein, Full-Length glycosylated H1N1 California/04/2009 with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 72 kDa.
Source:
Baculovirus Insect Cells.
Purity:
Greater than 90.0% under the conditions that would preserve its biological activity and tertiary structure.
Formulation:
The Recombinant H1N1 A/California/04/2009 solution 10mM Sodium phosphate pH-7, 150mM Sodium Chloride, and 0.005% Tween 20.
Stability:
The Recombinant H1N1 A/California/04/2009 Recombinant should be stored at 4 °C. Do NOT freeze!
Physical Appearance:
Sterile Filtered colorless solution.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
References:
1.Title:Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.
Publication: The Rockefeller University Press, doi: 10.1084/jem.20101352
© 2011 Wrammert et al.
Link:http://jem.rupress.org/content/early/2011/01/06/jem.20101352.full
"
